BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 20733280)

  • 21. The fate of inhaled drugs: the pharmacokinetics and pharmacodynamics of drugs administered by aerosol.
    Witek TJ
    Respir Care; 2000 Jul; 45(7):826-30. PubMed ID: 10926379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Superiority of "triple" therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPD.
    Singh D; Brooks J; Hagan G; Cahn A; O'Connor BJ
    Thorax; 2008 Jul; 63(7):592-8. PubMed ID: 18245142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A 4-year trial of tiotropium in chronic obstructive pulmonary disease.
    Tashkin DP; Celli B; Senn S; Burkhart D; Kesten S; Menjoge S; Decramer M;
    N Engl J Med; 2008 Oct; 359(15):1543-54. PubMed ID: 18836213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study.
    Donohue JF; Hanania NA; Ciubotaru RL; Noe L; Pasta DJ; Schaefer K; Claus R; Andrews WT; Roach J
    Clin Ther; 2008; 30 Spec No():989-1002. PubMed ID: 18640474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigating new standards for prophylaxis in reduction of exacerbations--the INSPIRE study methodology.
    Seemungal T; Stockley R; Calverley P; Hagan G; Wedzicha JA
    COPD; 2007 Sep; 4(3):177-83. PubMed ID: 17729060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of chronic obstructive pulmonary disease: moving beyond the asthma algorithm.
    Gordon E; Lazarus SC
    J Allergy Clin Immunol; 2009 Nov; 124(5):873-80; quiz 881-2. PubMed ID: 19895979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of chronic obstructive pulmonary disease].
    Fernández-Fernández FJ; Ameneiros-Lago E; González Moraleja J; Pía Iglesias G; Martínez-Debén FS; Sesma P
    An Med Interna; 2003 Mar; 20(3):148-55. PubMed ID: 12756902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TORCH and UPLIFT: what has been learned from the COPD "mega-trials"?
    Niewoehner DE
    COPD; 2009 Feb; 6(1):1-3. PubMed ID: 19229702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Long-term trials assessing pharmacological treatments in COPD: lessons and limitations].
    Marchand E
    Rev Mal Respir; 2010 Feb; 27(2):125-40. PubMed ID: 20206061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.
    Ohar JA; Donohue JF
    Semin Respir Crit Care Med; 2010 Jun; 31(3):321-33. PubMed ID: 20496301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tiotropium: a new, long-acting agent for the management of COPD--a clinical review.
    Crutchfield D
    Director; 2004; 12(3):160, 162-4. PubMed ID: 15323298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhaled albuterol/salbutamol and ipratropium bromide and their combination in the treatment of chronic obstructive pulmonary disease.
    Gordon J; Panos RJ
    Expert Opin Drug Metab Toxicol; 2010 Mar; 6(3):381-92. PubMed ID: 20163324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Debates surrounding COPD].
    Tillie-Leblond I; Housset B
    Rev Mal Respir; 2010 Feb; 27(2):106-7. PubMed ID: 20206057
    [No Abstract]   [Full Text] [Related]  

  • 34. Ultra-LAMA, ultra-LABA, ultra-inhaled steroids? The future has landed.
    Domingo C
    Arch Bronconeumol; 2013 Apr; 49(4):131-4. PubMed ID: 23415574
    [No Abstract]   [Full Text] [Related]  

  • 35. Additive benefits of tiotropium in COPD patients treated with long-acting beta agonists and corticosteroids.
    Perng DW; Wu CC; Su KC; Lee YC; Perng RP; Tao CW
    Respirology; 2006 Sep; 11(5):598-602. PubMed ID: 16916333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
    Lee TA; Wilke C; Joo M; Stroupe KT; Krishnan JA; Schumock GT; Pickard AS
    Arch Intern Med; 2009 Aug; 169(15):1403-10. PubMed ID: 19667304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen.
    Rascati KL; Akazawa M; Johnsrud M; Stanford RH; Blanchette CM
    Clin Ther; 2007 Jun; 29(6):1203-13. PubMed ID: 17692734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New evidence in pulmonary and preventive medicine.
    Dilaghi B; Modesti PA; Conti AA; Nozzoli C
    Intern Emerg Med; 2010 Apr; 5(2):157-9. PubMed ID: 20333483
    [No Abstract]   [Full Text] [Related]  

  • 39. Treating COPD in Older and Oldest Old Patients.
    Corsonello A; Scarlata S; Pedone C; Bustacchini S; Fusco S; Zito A; Incalzi RA
    Curr Pharm Des; 2015; 21(13):1672-89. PubMed ID: 25633118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical implications of ageing for rational drug therapy.
    Shi S; Mörike K; Klotz U
    Eur J Clin Pharmacol; 2008 Feb; 64(2):183-99. PubMed ID: 18180915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.